Riskpilot← Back to searchSign inGet full accessPharmat Oy
OYActiveY-tunnus 2855050-6Vuotie 45Retail sale of cosmetic and toilet articles · NACE 4775Est. 2017— employees
Revenue 2025
EUR 1,7M
-10% vs 2024
EBITDA margin
24.6%
-87% vs 2024
Equity ratio
97.7%
Financial strength
Net profit 2025
EUR 384K
-10% vs 2024
| Revenue | EUR 1,7M | -10% |
| EBITDA | EUR 414K | -87% |
| Net profit | EUR 384K | -10% |
| Total assets | EUR 2,6M | +10% |
| Equity | EUR 2,6M | +10% |
| Employees | — | — |
Legal name
Pharmat Oy
Y-tunnus number
2855050-6
Legal form
Osakeyhtiö
NACE code
4775 · Retail sale of cosmetic and toilet articles
Founded
8. syyskuuta 2017
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmisteiden, luontaistuotteiden, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaankaupan tuotteiden vähittäiskauppa, tukkukauppa, valmistus, maahantuonti ja maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipalvelut, kosmetologin palvelut, konsultointi- ja koulutuspalvelut ja henkilöstövuokraus. Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen.
Address
Vuotie 45
Phone
+358093434400
Email
marja.honkanen@apteekit.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 062 | 2 087 | 2 091 | 1 874 | 1 688 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | 532 | 3 632 | 531 | 3 278 | 414 |
| Depreciation & amort. | — | — | −0 | — | — |
| EBIT | 532 | 541 | 531 | 471 | 414 |
| Net financials | 18 | −28 | 22 | −12 | −19 |
| Profit before tax | 549 | 514 | 552 | 535 | 476 |
| Tax | 109 | 110 | 108 | 109 | −91 |
| Net profit | 441 | 404 | 444 | 425 | 384 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 560 | 1 847 | 2 143 | 2 398 | 2 627 |
| Equity | 1 470 | 1 757 | 2 057 | 2 333 | 2 567 |
| Long-term debt | — | — | 0 | — | — |
| Short-term debt | 90 | 91 | 86 | 65 | 60 |
| Total debt | 90 | 91 | 86 | 65 | 60 |
EBITDA margin
24.6%
This company
15.8%
Market median
+56% vs market
20212025
Equity ratio
97.7%
This company
38.2%
Market median
+156% vs market
20212025
Return on equity
15.0%
This company
18.4%
Market median
+18% vs market
20212025
Net profit margin
22.8%
This company
8.1%
Market median
+181% vs market
20212025
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SS Deputy Member | Deputy Member | 2017 |
ME Chief Executive Officer | Chief Executive Officer | 2017 |
| Former (1) | ||
JB Audit | Audit | 2017 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmat Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Seppo Sakari Honkanen | Deputy Member | 0 companies |
| Marja Elina Honkanen | Chief Executive Officer | 0 companies |
| Jan-Erik Björklöf | Audit | 0 companies |